Jesus an intelligent discussion on yahoo without: this sucker is going to the moon! or bankruptcy! and thieves in charge here!!
Many thanks to both of you.
I was merely making fun of the foolishness of the question; how it brings nothing to the table and is merely woolgathering of the silliest sort, without rhyme or reason, serving only to make us fat and myopic with useless speculations, as in: how many angels can fit on the head of a pin?
The company will succeed or fail on the strength of its immunotherapeutic solutions; let that come FIRST. Assume nothing until it does... keep your eye on that ball and be ready to bail if it doesn't.
So okay then! I'll sell you ALL my shares for $250... using your logic, that's a steal!
AWAITING YOUR CHECK!!!
PCYC, an a development-stage immunotherapy cancer company, is now mulling a sale of itself according to Bloomberg, and the stock is up 17% today... how much of today's price action in NWBO is related to that?
Jeez how can you afford all those exclamation points with what you make on these boards!!! You're quite the spendthrift!!!!!
Sentiment: Strong Buy
William Erbey, the billionaire founder, chairman and largest stockholder of one of the nation's largest mortgage-servicing firms, will resign from several of his corporate posts to "address serious conflicts of interest," a New York regulator announced Monday.
The news triggered an investor selloff that erased more than a quarter of the value from Ocwen Financial (OCN) shares. The Atlanta-based firm's stock closed down nearly 26.9% at $16.01. Shares of several firms related to Ocwen also droped sharply.
Erbey will step down from his post as executive chairman of Ocwen, according to the New York State Department of Financial Services.
He will also give up his positions as board chairman at four related companies with financial ties to Ocwen: Altisource Portfolio Solutions (ASPS); Altisource Residential (RESI); Altisource Asset Management (AAMC); and Home Loan Servicing Solutions (HLSS), said Benjamin Lawsky, superintendent of the New York agency.